Skip to main content
CG Oncology, Inc. (CGON)
NASDAQ: CGON · IEX Real-Time Price · USD
35.22
-1.50 (-4.08%)
At close: Jul 19, 2024, 4:00 PM
35.23
+0.01 (0.03%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021
Market Capitalization
2,347---
Enterprise Value
1,781-187-128-38
PS Ratio
4354.48---
PB Ratio
4.13---
EV/Sales Ratio
3304.20-917.71-667.73-3.71
EV/EBITDA Ratio
-3.373.603.11
EV/EBIT Ratio
-3.373.603.11
EV/FCF Ratio
-4.104.282.80
Debt / Equity Ratio
0.000.00-0.21-0.35
Debt / EBITDA Ratio
--0.01-0.45-1.22
Debt / FCF Ratio
--0.01-0.53-1.10
Quick Ratio
56.7613.179.328.97
Current Ratio
57.9513.629.549.78
Asset Turnover
-0.000.00-
Interest Coverage
---35442.00-27.47
Return on Equity (ROE)
-67.50%72.80%-
Return on Assets (ROA)
--39.10%-42.40%-
Return on Capital (ROIC)
-45.21%57.08%45.86%
Earnings Yield
-2.42%---
Buyback Yield / Dilution
-1158.12%-15.77%-2.47%-
Total Shareholder Return
-1158.12%-15.77%-2.47%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).